French study sheds light on rare Tick-Borne infections
NCT ID NCT07335965
First seen Jan 16, 2026 · Last updated Jun 06, 2026 · Updated 25 times
Summary
This study looks at cases of recurrent borreliosis, a bacterial infection spread by ticks or lice, that have been diagnosed in France. Researchers will describe the symptoms, where patients got infected, which Borrelia species caused it, and how it was diagnosed and treated. The goal is to better understand this rare but serious disease, which can cause fever, muscle pain, and even death in some cases.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BORRELIA RECURRENTIS INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Laboratoire de Bactériologie - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.